[A16-74] Palbociclib (breast cancer) - Benefit assessment according to §35a Social Code Book V
Last updated 01.03.2017
Project no.:
A16-74
Commission:
Commission awarded on 23.11.2016 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Cancer
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A18-63 | Palbociclib (breast cancer) - Benefit assessment according to §35a Social Code Book V (expiry of the decision) | Commission completed |
| A17-15 | Palbociclib (breast cancer) - Addendum to commission A16-74 | Commission completed |
| A22-66 | Palbociclib (breast cancer) – Benefit assessment according to § 35a SGB V | Commission completed |
Federal Joint Committee (G-BA)
2017-05-18 A G-BA decision was published.